BW
ZBH icon

Basepoint Wealth’s Zimmer Biomet ZBH Stock Holding History

Basepoint Wealth’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1K Sell
315
-67
-18% -$5.88K 0.02% 282
2026
Q1 		$34.5K Sell
382
-42
-10% -$3.85K 0.02% 260
2025
Q4 		$38.2K Buy
+424
New +$40.2K 0.02% 235
2024
Q1 		– Sell
-1,667
Closed -$203K – 121
2023
Q4 		$203K Sell
1,667
-567
-25% -$63.3K 0.16% 98
2023
Q3 		$251K Sell
2,234
-13
-0.6% -$1.65K 0.2% 88
2023
Q2 		$327K Sell
2,247
-245
-10% -$33.3K 0.27% 78
2023
Q1 		$322K Sell
2,492
-28
-1% -$3.52K 0.27% 74
2022
Q4 		$321K Buy
2,520
+4
+0.2% +$464 0.28% 70
2022
Q3 		$263K Sell
2,516
-268
-10% -$29.4K 0.28% 69
2022
Q2 		$292K Sell
2,784
-45
-2% -$5.34K 0.31% 69
2022
Q1 		$362K Sell
2,829
-222
-7% -$26.8K 0.33% 46
2021
Q4 		$376K Buy
+3,051
New +$399K 0.37% 47

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Basepoint Wealth's ZBH Position: Q2 2026 in Review

Basepoint Wealth reduced its Zimmer Biomet (ZBH) stake by 18% in Q2 2026, selling an estimated $5.88K and leaving 315 shares worth $27.1K. The position accounts for 0.02% of the portfolio, ranked #282.

Basepoint Wealth first reported a position in ZBH in Q4 2021 and has held it in 12 quarters since. The position peaked at $376K in Q4 2021. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Basepoint Wealth held 315 shares of Zimmer Biomet worth $27.1K as of Q2 2026.
  • Basepoint Wealth sold 67 Zimmer Biomet shares in Q2 2026, an estimated $5.88K.
  • Zimmer Biomet made up 0.02% of Basepoint Wealth's portfolio in Q2 2026, its #282 holding.
  • Basepoint Wealth first reported a position in Zimmer Biomet in Q4 2021 and has held it in 12 quarters since.
  • Basepoint Wealth's Zimmer Biomet position peaked at $376K in Q4 2021.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Basepoint Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.